Related Experiment Videos
Seizure-like phenomena and propofol: a systematic review
Bernhard Walder1, Martin R Tramèr, Margitta Seeck
1Department APSIC, Functional Neurology and Neurosurgery Program of the University of Geneva, Switzerland. Bernard.Walder@hcuge.ch
Neurology
|May 23, 2002
Summary
Seizure-like phenomena (SLP) can occur in patients receiving propofol, regardless of epilepsy history. The timing of these events suggests propofol concentration changes may be a cause, but more data is needed.
Area of Science:
- Anesthesiology
- Neuroscience
- Pharmacology
Background:
- Propofol is a widely used anesthetic agent.
- Seizure-like phenomena (SLP) have been anecdotally reported in patients receiving propofol.
- The relationship between propofol administration and SLP requires further investigation.
Purpose of the Study:
- To systematically review and classify SLP in patients who received propofol.
- To analyze the timing and clinical presentation of SLP during and after propofol administration.
- To explore potential correlations between propofol and SLP.
Main Methods:
- Systematic review of case reports detailing SLP in propofol-recieving patients.
- Classification of SLP based on occurrence time (induction, maintenance, emergence, delayed) and clinical presentation.
- Analysis of patient data, including epilepsy status and diagnostic workup (EEG, neurological consultation).
Main Results:
- SLP occurred in 70 patients without epilepsy (34% induction, 40% emergence, 23% delayed) and 11 patients with epilepsy (64% during emergence).
- Most common presentations included generalized tonic-clonic seizures (43%), increased tone with twitching (36%), and involuntary movements (16%).
- Diagnostic workup was limited, with only 32% having an EEG and 15% a neurological consultation.
Conclusions:
- SLP can manifest in patients with or without epilepsy during propofol anesthesia or sedation.
- The temporal occurrence of SLP suggests a potential link to fluctuating propofol cerebral concentrations.
- Higher quality data is essential to confirm causality, determine prevalence, and identify risk factors for propofol-related SLP.